Trump’s Most Favored Nation Drug Pricing Has Bold Aims, But Limited Impact
The Trump administration is implementing Most Favored Nation (MFN) policies to align U.S. prescription drug prices with those in other wealthy nations. These initiatives, including a Medicaid model called GENEROUS and a TrumpRx platform, aim to reduce drug costs. However, critics question the actual impact and transparency of these deals, noting that the program's savings projections are dubious and the agreements are largely confidential. AI
